Expertise in
3
conditions

Dr. Vivek K. Arora

Internal Medicine
Aurora Medical Center Kenosha
10400 75th St, 
Kenosha, WI 
Accepting New Patients
Offers Telehealth
Expertise in
3
conditions
Aurora Medical Center Kenosha
10400 75th St, 
Kenosha, WI 

Overview

Vivek Arora is a primary care provider, practicing in Internal Medicine in Kenosha, Wisconsin.

Dr. Arora is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Magnesium Deficiency, Gitelman Syndrome, Sitosterolemia, Thrombectomy, and Endoscopy.

He is actively involved in clinical research, co-authoring 71 peer reviewed articles and participating in 8 clinical trials. Dr. Arora is currently accepting new patients.

Specialties

Internal Medicine

Licenses

Internal Medicine in IL

Hospital Affiliations

Aurora Medical Center Kenosha
Advocate Condell Medical Center
Vista Medical Center East
Northwestern Lake Forest Hospital
Northshore University Healthsystem - Evanston Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Aspirus Arise Health
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareSource
  • HMO
Celtic
  • HMO
  • INSURANCE PLAN
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Common Ground Healthcare
  • OTHER COMMERCIAL
Common Ground Healthcare Cooperative
  • EPO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Quartz
  • HMO
  • POS
  • PPO
TeamCare
  • OTHER COMMERCIAL
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Zing Health
  • MEDICARE MAPD
  • MEDICARE SNP
View 24 Less Insurance Carriers -

Locations

Aurora Medical Center Kenosha
10400 75th St, Kenosha, WI 53142

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase II Study of Gemcitabine Plus Cisplatin Chemotherapy in Patients With Muscle-invasive Bladder Cancer With Bladder Preservation for Those Patients Whose Tumors Harbor Deleterious DNA Damage Response (DDR) Gene Alterations
A Phase II Study of Gemcitabine Plus Cisplatin Chemotherapy in Patients With Muscle-invasive Bladder Cancer With Bladder Preservation for Those Patients Whose Tumors Harbor Deleterious DNA Damage Response (DDR) Gene Alterations
Enrollment Status: Active_not_recruiting
Publish Date: April 13, 2026
Intervention Type: Procedure, Drug, Biological, Other
Study Drugs: Gemcitabine, Cisplatin, Pegfilgrastim
Study Phase: Phase 2
A Phase 1b Clinical Trial of Cabozantinib and Abiraterone With Checkpoint Inhibitor Immunotherapy in Metastatic Hormone Sensitive Prostate Cancer (CABIOS Trial)
A Phase 1b Clinical Trial of Cabozantinib and Abiraterone With Checkpoint Inhibitor Immunotherapy in Metastatic Hormone Sensitive Prostate Cancer (CABIOS Trial)
Enrollment Status: Completed
Publish Date: November 12, 2025
Intervention Type: Drug, Procedure
Study Drugs: Cabozantinib, Nivolumab, Abiraterone, Prednisone
Study Phase: Phase 1
A Single Arm, Multicenter, Phase 2 Trial to Evaluate the Efficacy of Lenvatinib (LEN) in Combination With Pembrolizumab (KEYtruda) in Subjects With Locally Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma (The LENKYN Trial)
A Single Arm, Multicenter, Phase 2 Trial to Evaluate the Efficacy of Lenvatinib (LEN) in Combination With Pembrolizumab (KEYtruda) in Subjects With Locally Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma (The LENKYN Trial)
Enrollment Status: Terminated
Publish Date: March 21, 2025
Intervention Type: Procedure, Drug
Study Drugs: Lenvatinib, Pembrolizumab
Study Phase: Phase 2
A Phase 2 Study of Ibrutinib as Neoadjuvant Therapy in Patients With Localized Prostate Cancer
A Phase 2 Study of Ibrutinib as Neoadjuvant Therapy in Patients With Localized Prostate Cancer
Enrollment Status: Completed
Publish Date: January 08, 2025
Intervention Type: Procedure, Drug
Study Drug: Ibrutinib
Study Phase: Phase 2
A Phase IB Open-label, Dose Escalation and Expansion Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK525762 in Combination With Androgen Deprivation Therapy and Other Agents in Subjects With Castrate-resistant Prostate Cancer (CRPC)
A Phase IB Open-label, Dose Escalation and Expansion Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK525762 in Combination With Androgen Deprivation Therapy and Other Agents in Subjects With Castrate-resistant Prostate Cancer (CRPC)
Enrollment Status: Terminated
Publish Date: August 10, 2022
Intervention Type: Drug
Study Drugs: GSK525762, Abiraterone, Enzalutamide, Prednisone
Study Phase: Phase 1
A Pilot Trial of Neoantigen DNA Vaccine in Combination With Nivolumab/Ipilimumab and PROSTVAC in Metastatic Hormone-Sensitive Prostate Cancer
A Pilot Trial of Neoantigen DNA Vaccine in Combination With Nivolumab/Ipilimumab and PROSTVAC in Metastatic Hormone-Sensitive Prostate Cancer
Enrollment Status: Completed
Publish Date: August 05, 2022
Intervention Type: Biological, Drug, Device, Procedure
Study Drugs: Nivolumab, Ipilimumab, PROSTVAC Shared Antigen Vaccine, Neoantigen DNA Vaccine
Study Phase: Phase 1
A Randomized Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Hormone-Sensitive Prostate Cancer
A Randomized Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Hormone-Sensitive Prostate Cancer
Enrollment Status: Completed
Publish Date: September 16, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Randomized Phase II PIVOT-RCC (PolyImmune {Durvalumab (MEDI4736) and Tremelimumab} & Vaccine Orchestrated Treatment for Patients With Advanced/Metastatic Renal Cell Carcinoma) Trial
A Randomized Phase II PIVOT-RCC (PolyImmune {Durvalumab (MEDI4736) and Tremelimumab} & Vaccine Orchestrated Treatment for Patients With Advanced/Metastatic Renal Cell Carcinoma) Trial
Enrollment Status: Withdrawn
Publish Date: August 13, 2020
Intervention Type: Procedure, Device, Drug, Biological
Study Phase: Phase 2
View 7 Less Clinical Trials

71 Total Publications

Corrigendum to "Somatic DICER1-mutated Sertoli-Leydig cell tumor in a postmenopausal woman: eight years of peritoneal relapse managed with cytoreductive surgery and HIPEC - a case report" [Case Rep. Women's Health. 51 (2026) e00849].
Corrigendum to "Somatic DICER1-mutated Sertoli-Leydig cell tumor in a postmenopausal woman: eight years of peritoneal relapse managed with cytoreductive surgery and HIPEC - a case report" [Case Rep. Women's Health. 51 (2026) e00849].
Journal: Case reports in women's health
Published: September 05, 2026
Similar Doctors
Expertise in
28
conditions
Dr. Alok K. Srivastava
Internal Medicine
Expertise in
28
conditions
Dr. Alok K. Srivastava
Internal Medicine

Aurora Internal Medicine

818 Forrest Ln, 
Waterford, WI 
 (19.1 miles away)
262-514-3700
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients

Alok Srivastava is a primary care provider, practicing in Internal Medicine in Waterford, Wisconsin. Dr. Srivastava is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Hemophilia A, Blood Clots, Beta Thalassemia, Kidney Transplant, and Nephrectomy. Dr. Srivastava is board certified in American Board Of Internal Medicine. Dr. Srivastava is currently accepting new patients.

Expertise in
15
conditions
Dr. Ami A. Shah
Internal Medicine
Expertise in
15
conditions
Dr. Ami A. Shah
Internal Medicine

Advocate Lutheran General Hospital

1775 Dempster St, 
Park Ridge, IL 
 (37.0 miles away)
847-723-2210
Languages Spoken:
English
See accepted insurances

Ami Shah is a primary care provider, practicing in Internal Medicine in Park Ridge, Illinois. Dr. Shah is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Scleroderma, Systemic Sclerosis (SSc), Raynaud Phenomenon, and Myositis.

Expertise in
8
conditions
Dr. Robert E. Molokie
Internal Medicine
Expertise in
8
conditions
Dr. Robert E. Molokie
Internal Medicine

University Of Illinois Hospital

1740 W Taylor St, 
Chicago, IL 
 (50.3 miles away)
312-413-8666
Languages Spoken:
English
See accepted insurances

Robert Molokie is a primary care provider, practicing in Internal Medicine in Chicago, Illinois. Dr. Molokie is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, and Hemolytic Anemia.

Frequently Asked Questions about Dr. Vivek K. Arora

How do I make an appointment with Dr. Vivek K. Arora?

You can book an appointment with Dr. Vivek K. Arora by calling their office at 262-948-7000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Vivek K. Arora a top-rated expert for Magnesium Deficiency?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Vivek K. Arora is classified as an Distinguished expert for Magnesium Deficiency, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Vivek K. Arora specialize in?

While Dr. Vivek K. Arora is a Internal Medicine, they have specific expertise in Magnesium Deficiency, Gitelman Syndrome, and Sitosterolemia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Vivek K. Arora participate in research or clinical trials?

Yes. Dr. Vivek K. Arora has published 71 articles and abstracts on conditions like Magnesium Deficiency. You can view a list of Dr. Vivek K. Arora's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Vivek K. Arora accept my insurance?

Dr. Vivek K. Arora accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 262-948-7000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Arora's expertise for a condition
ConditionClose
    View All 76 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile